BENAZEPRIL HYDROCHLORIDE TABLETS

Zhejiang Huahai Pharmaceutical Co Ltd

Revision date : 2015-10-17

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08
Health risk rating 5
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

9004-34-6

Name of the chemical

cellulose

Concentration

10-40

EC/CAS

9005-25-8

Name of the chemical

Starch

Concentration

<10 <10

General Information

Version

005A

Revision date

2015-10-17

Product name

BENAZEPRIL HYDROCHLORIDE TABLETS

Product Synonyms

Benazepril Hydrochloride Tablets, USP, 5mg

1.2.2. Uses advised against

No other uses are advised

Manufacturer Name

Zhejiang Huahai Pharmaceutical Co Ltd

Emergency telephone

008657685016474

Icons in SDS

GHS08

Company Information

company name

Zhejiang Huahai Pharmaceutical Co Ltd

e-mail address of the competent person responsible for the Safety Data Sheet

leikewei@huahaipharm.com

GHS Information

Signal word

Warning

Section 2

SECTION 2: Hazards identification

OSHA defined hazards Classified hazards

Physical hazards

Not classified

Health hazards

Reproductive toxicity Category 2 Specific target organ toxicity, repeated exposure Category 2 (cardiovascular system)

2.2 Label elements

INDICATIONS AND USAGE Benazepril hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. WARNINGS AND PRECAUTIONS  Angioedema: Discontinue benazepril hydrochloride and treat appropriately.  Monitor renal function periodically.  Monitor blood pressure after initiation.  Hyperkalemia: Monitor serum potassium periodically.  Hepatic toxicity: Monitor for jaundice or signs of liver failure. Hazard(s) not otherwise classified (HNOC) Available hazard identification for Active Pharmaceutical Ingredient (API) alone

Signal word

Warning

Hazard statements

Suspected of damaging fertility or the unborn child. May cause damage to organs (cardiovascular system) through prolonged or repeated exposure.

Prevention

Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves/protective clothing/eye protection/face protection.

Response

If exposed or concerned: Get medical advice/attention..

Storage

Store locked up.

Disposal

I Dispose of contents/container to an approved disposal site.

2.1 Classification of the substance or mixture

Physical hazards: Not classified. Health hazards: Reproductive toxicity Category 2 Specific target organ toxicity, repeated exposure Category 2 (cardiovascular system) OSHA defined hazards: Not classified.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.